vs
AtriCure, Inc.（ATRC）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
AtriCure, Inc.的季度营收约是RESOURCES CONNECTION, INC.的1.2倍（$140.5M vs $117.7M），AtriCure, Inc.同比增速更快（13.1% vs -19.2%），AtriCure, Inc.自由现金流更多（$18.4M vs $15.6M），过去两年AtriCure, Inc.的营收复合增速更高（13.6% vs -11.8%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
ATRC vs RGP — 直观对比
营收规模更大
ATRC
是对方的1.2倍
$117.7M
营收增速更快
ATRC
高出32.2%
-19.2%
自由现金流更多
ATRC
多$2.9M
$15.6M
两年增速更快
ATRC
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $140.5M | $117.7M |
| 净利润 | — | $-12.7M |
| 毛利率 | 75.0% | 37.1% |
| 营业利润率 | 1.8% | -10.3% |
| 净利率 | — | -10.8% |
| 营收同比 | 13.1% | -19.2% |
| 净利润同比 | — | 81.6% |
| 每股收益（稀释后） | $0.04 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCRGP
| Q4 25 | $140.5M | $117.7M | ||
| Q3 25 | $134.3M | $120.2M | ||
| Q2 25 | $136.1M | $139.3M | ||
| Q1 25 | $123.6M | $129.4M | ||
| Q4 24 | $124.3M | $145.6M | ||
| Q3 24 | $115.9M | $136.9M | ||
| Q2 24 | $116.3M | $148.2M | ||
| Q1 24 | $108.9M | $151.3M |
净利润ATRCRGP
| Q4 25 | — | $-12.7M | ||
| Q3 25 | $-267.0K | $-2.4M | ||
| Q2 25 | $-6.2M | $-73.3M | ||
| Q1 25 | $-6.7M | $-44.1M | ||
| Q4 24 | — | $-68.7M | ||
| Q3 24 | $-7.9M | $-5.7M | ||
| Q2 24 | $-8.0M | $10.5M | ||
| Q1 24 | $-13.3M | $2.5M |
毛利率ATRCRGP
| Q4 25 | 75.0% | 37.1% | ||
| Q3 25 | 75.5% | 39.5% | ||
| Q2 25 | 74.5% | 40.2% | ||
| Q1 25 | 74.9% | 35.1% | ||
| Q4 24 | 74.5% | 38.5% | ||
| Q3 24 | 74.9% | 36.5% | ||
| Q2 24 | 74.7% | 40.2% | ||
| Q1 24 | 74.7% | 37.0% |
营业利润率ATRCRGP
| Q4 25 | 1.8% | -10.3% | ||
| Q3 25 | 0.2% | -1.7% | ||
| Q2 25 | -4.5% | -47.0% | ||
| Q1 25 | -4.8% | -38.4% | ||
| Q4 24 | -11.7% | -52.7% | ||
| Q3 24 | -6.4% | -3.5% | ||
| Q2 24 | -6.2% | 7.6% | ||
| Q1 24 | -10.0% | 2.8% |
净利率ATRCRGP
| Q4 25 | — | -10.8% | ||
| Q3 25 | -0.2% | -2.0% | ||
| Q2 25 | -4.5% | -52.6% | ||
| Q1 25 | -5.5% | -34.0% | ||
| Q4 24 | — | -47.2% | ||
| Q3 24 | -6.8% | -4.2% | ||
| Q2 24 | -6.9% | 7.1% | ||
| Q1 24 | -12.2% | 1.7% |
每股收益（稀释后）ATRCRGP
| Q4 25 | $0.04 | $-0.38 | ||
| Q3 25 | $-0.01 | $-0.07 | ||
| Q2 25 | $-0.13 | $-2.21 | ||
| Q1 25 | $-0.14 | $-1.34 | ||
| Q4 24 | $-0.33 | $-2.08 | ||
| Q3 24 | $-0.17 | $-0.17 | ||
| Q2 24 | $-0.17 | $0.31 | ||
| Q1 24 | $-0.28 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.4M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $491.9M | $194.6M |
| 总资产 | $654.2M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCRGP
| Q4 25 | $167.4M | $89.8M | ||
| Q3 25 | $147.9M | $77.5M | ||
| Q2 25 | $117.8M | $86.1M | ||
| Q1 25 | $99.9M | $72.5M | ||
| Q4 24 | $122.7M | $78.2M | ||
| Q3 24 | $130.3M | $89.6M | ||
| Q2 24 | $114.0M | $108.9M | ||
| Q1 24 | $106.0M | $113.8M |
总债务ATRCRGP
| Q4 25 | — | — | ||
| Q3 25 | $61.9M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $61.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.9M | — | ||
| Q2 24 | $61.9M | — | ||
| Q1 24 | $61.9M | — |
股东权益ATRCRGP
| Q4 25 | $491.9M | $194.6M | ||
| Q3 25 | $476.5M | $206.4M | ||
| Q2 25 | $464.5M | $207.1M | ||
| Q1 25 | $454.6M | $277.8M | ||
| Q4 24 | $461.0M | $325.7M | ||
| Q3 24 | $465.0M | $407.2M | ||
| Q2 24 | $462.1M | $418.8M | ||
| Q1 24 | $456.3M | $414.9M |
总资产ATRCRGP
| Q4 25 | $654.2M | $289.3M | ||
| Q3 25 | $635.4M | $287.2M | ||
| Q2 25 | $608.8M | $304.7M | ||
| Q1 25 | $591.6M | $375.6M | ||
| Q4 24 | $609.3M | $424.9M | ||
| Q3 24 | $615.1M | $512.9M | ||
| Q2 24 | $597.3M | $510.9M | ||
| Q1 24 | $591.6M | $523.2M |
负债/权益比ATRCRGP
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $18.4M | $15.6M |
| 自由现金流率自由现金流/营收 | 13.1% | 13.2% |
| 资本支出强度资本支出/营收 | 1.1% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $48.3M | $24.3M |
8季度趋势，按日历期对齐
经营现金流ATRCRGP
| Q4 25 | $20.0M | $15.9M | ||
| Q3 25 | $26.7M | $-7.8M | ||
| Q2 25 | $21.6M | $16.8M | ||
| Q1 25 | $-11.0M | $659.0K | ||
| Q4 24 | $5.8M | $1.8M | ||
| Q3 24 | $20.0M | $-309.0K | ||
| Q2 24 | $7.4M | $3.2M | ||
| Q1 24 | $-21.0M | $20.5M |
自由现金流ATRCRGP
| Q4 25 | $18.4M | $15.6M | ||
| Q3 25 | $24.1M | $-8.0M | ||
| Q2 25 | $19.0M | $16.5M | ||
| Q1 25 | $-13.2M | $238.0K | ||
| Q4 24 | $3.1M | $61.0K | ||
| Q3 24 | $16.4M | $-575.0K | ||
| Q2 24 | $5.0M | $3.0M | ||
| Q1 24 | $-23.8M | $20.4M |
自由现金流率ATRCRGP
| Q4 25 | 13.1% | 13.2% | ||
| Q3 25 | 18.0% | -6.6% | ||
| Q2 25 | 13.9% | 11.8% | ||
| Q1 25 | -10.7% | 0.2% | ||
| Q4 24 | 2.5% | 0.0% | ||
| Q3 24 | 14.1% | -0.4% | ||
| Q2 24 | 4.3% | 2.1% | ||
| Q1 24 | -21.9% | 13.5% |
资本支出强度ATRCRGP
| Q4 25 | 1.1% | 0.3% | ||
| Q3 25 | 1.9% | 0.1% | ||
| Q2 25 | 2.0% | 0.2% | ||
| Q1 25 | 1.8% | 0.3% | ||
| Q4 24 | 2.2% | 1.2% | ||
| Q3 24 | 3.1% | 0.2% | ||
| Q2 24 | 2.1% | 0.1% | ||
| Q1 24 | 2.5% | 0.1% |
现金转化率ATRCRGP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage Management | $45.5M | 32% |
| Openheart | $38.5M | 27% |
| Other | $26.2M | 19% |
| Pain Management | $22.6M | 16% |
| Minimally Invasive | $7.7M | 6% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
